PTPN11 and acute myeloid leukemia: Additionally, activating mutations in SHP2, such as E76K, disrupt the autoinhibitory interaction between the N-SH2 and PTP domains in acute myeloid leukemia (AML), resulting in constitutive PTP activation and accelerated leukemic cell proliferation [9,17].